Zykadia
Zykadia is a medicine authorised by Swissmedic under authorisation number 67233. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 March 2020 and the authorisation is valid without a time limit. ATC code L01ED02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67233 |
|---|---|
| Name | Zykadia |
| Full name | Zykadia, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01ED02 |
| First authorisation | 16 March 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zykadia, Filmtabletten | A | 16 March 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 84 | Tablette(n) | L01ED02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Zykadia authorised in Switzerland?
Yes. Zykadia is authorised by Swissmedic under authorisation number 67233, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zykadia have?
Zykadia is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Zykadia?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.